In this episode of Beauty & The Brain, Dr. Chris Croley and NP Jerry Drinkard break down the most in-demand medications in modern weight loss and metabolic health: GLP-1 medications, including semaglutide, tirzepatide, Wegovy, Ozempic, and Zepbound.

Together, they explore how these drugs actually work, who they help most, and the unexpected ways they impact the body far beyond weight loss.

Inside this episode, you’ll learn:

• How GLP-1 medications regulate appetite, cravings, inflammation & blood sugar
• The shift from compounded semaglutide to manufacturer-direct options
• Why some patients experience fertility changes, libido shifts, hair thinning & mood effects
• The rise of microdosing GLP-1s to reduce nausea, fatigue & muscle loss
• Anti-aging and neuroprotective research emerging around GLP-1 therapy
• Why rapid weight loss accelerates facial aging—and how Sculptra can help preserve structure
• How exercise, protein intake & body composition affect long-term results

Whether you're a patient using GLP-1 therapy or a provider prescribing it, this episode offers evidence-based insight, real patient experiences, and practical solutions for navigating side effects and treatment longevity.

Follow Beauty & The Brain for weekly conversations on aesthetic medicine, regenerative wellness, weight-loss science, and the future of medical aesthetics.

GLP-1, semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, medical weight loss, aesthetic medicine, Sculptra, microdosing GLP-1